About BlueWillow Biologics
BlueWillow Biologics is a private company based in Ann Arbor, Michigan. It has reported $35,020,836 raised in eight offerings on Form D since May 2009. Its chief executive is Chad Costley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 2024 | Feb 12, 2024 | $850,000of $3.0M target | 2 | $425K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 19, 2022 | Oct 14, 2022 | $5,895,312of $8.0M target | 16 | $368K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 31, 2020 | Apr 8, 2020 | $8,190,705of $10.0M target | 19 | $431K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 28, 2019 | Sep 5, 2019 | $800,000of $3.0M target | 4 | $200K | DebtRule 506(b) | Form D ↗ |
| Feb 16, 2018 | May 30, 2018 | $6,709,819of $9.2M target | 17 | $394K | EquityRule 506(b) | Form D ↗ |
| Jan 31, 2017 | Feb 15, 2017 | $775,000of $1.0M target | 5 | $155K | Debt, Convertible NotesRule 506(b) | Form D ↗ |
| Dec 22, 2015 | Feb 4, 2016 | $1,800,000of $5.0M target | 6 | $300K | Convertible NotesRule 506(b) | Form D ↗ |
| Aug 23, 2008 | May 29, 2009 | $10,000,000target not set | 3 | $3.3M | Senior Convertible Notes06 | Form D/A ↗ |
| Total, eight offerings | $35,020,836 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BlueWillow Biologics's Form D filed Feb 12, 2024.
Earlier filings also listed Gary Costley (director, last listed Oct 2022), Angela Harris (director, last listed Oct 2022), David Peralta (president and ceo, director, last listed Apr 2020), James Baker, Jr. (director, last listed Feb 2017), Peter Ulrich (director, last listed Feb 2016), Ronald Cresswell (director, last listed May 2009), Robert Moellering (director, last listed May 2009) and Norman Selby (director, last listed May 2009).